Microbial translocation and metabolic and body composition measures in treated and untreated HIV infection

Tamara Timmons1, Changyu Shen, Grace Aldrovandi

  • 11 Department of Medicine, University of Southern California Keck School of Medicine , Los Angeles, California.

Insights

HIV infection is linked to increased microbial translocation markers, which correlate with insulin resistance and dyslipidemia. Long-term antiretroviral therapy (ART) may worsen these effects, particularly impacting HDL cholesterol and cardiovascular risk.

Area of Science:

  • Infectious Diseases
  • Metabolic Syndrome
  • Cardiovascular Health

Background:

  • Circulating microbial products like lipopolysaccharide (LPS) are elevated in HIV infection.
  • Microbial translocation is associated with metabolic dysfunction, including insulin resistance and dyslipidemia.
  • Antiretroviral therapy (ART) is crucial for HIV management but may have metabolic implications.

Purpose of the Study:

  • To investigate the relationship between microbial translocation markers (LPS and soluble CD14) and metabolic/body composition measures in individuals with HIV.
  • To assess how these relationships differ between individuals on and not on ART, and during ART initiation.
  • To explore the potential contribution of microbial translocation to cardiovascular disease risk in treated HIV patients.

Main Methods:

  • Analysis of data from 178 subjects across a cross-sectional study and a prospective ART initiation study.
  • Utilized Pearson correlations to examine associations between plasma LPS, soluble CD14 (sCD14), and metabolic parameters (HOMA-IR, triglycerides, HDL cholesterol, body composition).
  • Included measurements of large particle HDL by NMR spectroscopy.

Main Results:

  • Plasma LPS correlated positively with insulin resistance (HOMA-IR) and triglycerides across combined cohorts.
  • Soluble CD14 (sCD14) showed negative correlations with high-density lipoprotein (HDL) cholesterol and lean/fat mass.
  • LPS was negatively associated with large particle HDL, particularly in subjects on ART, suggesting a link to adverse lipoprotein profiles.

Conclusions:

  • Microbial translocation markers are associated with adverse metabolic effects, especially concerning lipoproteins, in HIV-infected individuals.
  • Prolonged ART may exacerbate these effects, negatively impacting large HDL particles.
  • These findings suggest microbial translocation may contribute to the elevated cardiovascular disease risk observed in chronically treated HIV patients.